BLK
BLK (tyrosine-protein kinase Blk, previously B lymphoid tyrosine kinase) is a non-receptor tyrosine kinase of the Src family. It is involved in B-lymphocyte development, differentiation and signalling, and also modulates pancreatic beta-cell function. Browse Assay Genie's current range of BLK research reagents below, or read on for the biology behind the target.
BLK is a non-receptor tyrosine kinase that acts in B-cell receptor (BCR) signalling, which depends on tight regulation of several protein tyrosine kinases, phosphatases and associated coreceptors. When antigen binds the BCR, the resulting signalling leads to B-cell activation. BLK transmits signals through surface immunoglobulins and supports the pro-B to pre-B transition, as well as the signalling for growth arrest and apoptosis downstream of the BCR.
BLK binds and phosphorylates CD79A at Tyr-188 and Tyr-199 and CD79B at Tyr-196 and Tyr-207. It also phosphorylates the immunoglobulin G receptors FCGR2A, FCGR2B and FCGR2C. Together with FYN and LYN, it is essential for pre-B-cell receptor-mediated NF-kappa-B activation, and it contributes to BTK activation by indirectly stimulating BTK intramolecular autophosphorylation. Outside the immune system, BLK acts in pancreatic islets, where it up-regulates PDX1 and NKX6-1 and so stimulates insulin secretion in response to glucose. It also phosphorylates CGAS, promoting retention of CGAS in the cytosol.
The BLK gene belongs to the protein kinase superfamily, Tyr protein kinase family, SRC subfamily, and is classed by HGNC among the SH2 domain containing and SH3 domain containing genes and the Src family tyrosine kinases. Src-family proto-oncogenes are typically involved in cell proliferation and differentiation. The protein localises to the cell membrane, and the gene has a mouse ortholog, Blk. Earlier nomenclature includes the symbol MGC10442 and the name B lymphoid tyrosine kinase.
BLK transmits signals through surface immunoglobulins and phosphorylates CD79A and CD79B after antigen binds the B-cell receptor.
BLK supports the pro-B to pre-B transition and, with FYN and LYN, pre-BCR-mediated NF-kappa-B activation.
BLK up-regulates PDX1 and NKX6-1 and stimulates insulin secretion in response to glucose in pancreatic islets.
As a Src-family proto-oncogene product, BLK is a model for studying kinase roles in proliferation, differentiation and innate signalling via CGAS.
BLK is a non-receptor tyrosine kinase involved in B-lymphocyte development, differentiation and signalling. It phosphorylates CD79A and CD79B downstream of the B-cell receptor, and in pancreatic islets it promotes glucose-stimulated insulin secretion by up-regulating PDX1 and NKX6-1.
The HGNC name is BLK proto-oncogene, Src family tyrosine kinase, and UniProt lists the protein as tyrosine-protein kinase Blk. The previous name is B lymphoid tyrosine kinase, and MGC10442 is a previous symbol. The enzyme is classified as EC 2.7.10.2.
A mouse ortholog, Blk, is recorded for the human gene. BLK belongs to the SRC subfamily of the Tyr protein kinase family, which is typically involved in cell proliferation and differentiation. Check the datasheet of any product for its validated reactivity.
Other Src-family kinases, B-cell receptor signalling components and pancreatic beta-cell transcription factors with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P51451; product specifications from Assay Genie datasheets.